Key Metrics
CiteScore 

4.5
Impact Factor 

< 5
SJR 

Q3Biological Psychiatry

SNIP 

1.09
Recommended pre-submission checks
Powered by 

Topics Covered on Neuropsychiatric Disease and Treatment
Neuropsychiatric Disease and Treatment Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2836 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Neuropsychiatric Disease and Treatment ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Neuropsychiatric Disease and Treatment
The Influence of Lifestyle on Cognitive Function and Quality of Life in People with Dementia
- 3 Apr 2026
- Neuropsychiatric Disease and Treatment
Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study
- 3 Apr 2026
- Neuropsychiatric Disease and Treatment
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment
Wavelet Entropy Analysis of EEG Signals During Wake and Sleep in Patients with Alzheimer’s Disease: A Pilot Study
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment
Parallel Single-Tissue Summary-Data Mendelian Randomization and Functional Validation Identify the ARRDC1 Promoter SNP rs4494021 as a Genetic Marker Associated with Anxiety Disorders.
- 1 Apr 2026
- Neuropsychiatric disease and treatment
Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment
The Influence of Lifestyle on Cognitive Function and Quality of Life in People with Dementia
- 3 Apr 2026
- Neuropsychiatric Disease and Treatment
Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study
- 3 Apr 2026
- Neuropsychiatric Disease and Treatment
Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment
Wavelet Entropy Analysis of EEG Signals During Wake and Sleep in Patients with Alzheimer’s Disease: A Pilot Study
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment
Parallel Single-Tissue Summary-Data Mendelian Randomization and Functional Validation Identify the ARRDC1 Promoter SNP rs4494021 as a Genetic Marker Associated with Anxiety Disorders.
- 1 Apr 2026
- Neuropsychiatric disease and treatment
Clinical Efficacy of Integrated Acupuncture and Moxibustion Therapy Combined with Drugs in the Treatment of Acute Depressive Disorder: Protocol for a Pragmatic Randomized Controlled Trial
- 1 Apr 2026
- Neuropsychiatric Disease and Treatment